Moderna price target lowered to $26 from $32 at BofA | Markets Insider

Retrieved on: 2025-04-24 20:39:48

Tags for this article:

Click the tags to see associated articles and topics

Moderna price target lowered to $26 from $32 at BofA | Markets Insider. View article details on hiswai:

Excerpt

BofA lowered the firm's price target on Moderna (MRNA) to $26 from $32 and keeps an Underperform rating on the shares. For 2025, the firm's reve.

Article found on: markets.businessinsider.com